Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lan Coffman

Clinical trials sponsored by Lan Coffman, explained in plain language.

Trials to join now! 1

New drug combo aims to outsmart recurrent ovarian cancer

Disease control Recruiting now

This trial tests a new experimental drug called CPI-0209 (Tulmimetostat) combined with the chemotherapy drug carboplatin in women whose ovarian cancer has returned but still responds to platinum-based treatments. The study aims to find the safest dose of CPI-0209 when given with …

Phase 1 • Sponsor: Lan Coffman • Aim: Disease control

Last updated Jul 10, 2026 00:00 UTC